meglumine has been researched along with Menopause in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alili, C; Bouic-Pages, E; Curros-Doyon, F; Millet, I; Molinari, N; Prat, X; Taourel, P | 1 |
| Kimura, M; Sakai, K; Seki, H | 1 |
1 trial(s) available for meglumine and Menopause
| Article | Year |
|---|---|
Myometrial invasion of endometrial carcinoma: assessment with dynamic MR and contrast-enhanced T1-weighted images.
Topics: Adult; Aged; Contrast Media; Diagnostic Errors; Drug Combinations; Endometrial Neoplasms; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Menopause; Middle Aged; Myometrium; Neoplasm Invasiveness; Organometallic Compounds; Pentetic Acid; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity | 1997 |
1 other study(ies) available for meglumine and Menopause
| Article | Year |
|---|---|
Invasive breast carcinoma: influence of prognosis and patient-related factors on kinetic MR imaging characteristics.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Meglumine; Menopause; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Organometallic Compounds; Prognosis; Retrospective Studies; Risk Factors | 2014 |